Improved 24-hour plasma glucose profile in patients with type 2 diabetes treated with Humalog® Mix25™

被引：0
|
作者：
Herz, M
Arora, V
Mollentze, W
机构：
来源：
DIABETES | 2001年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A117 / A117
页数：1
相关论文
共 50 条
  • [1] Humalog Mix25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus
    Herz, M
    Arora, V
    Campaigne, BN
    Scholtz, HE
    Potgieter, MA
    Mollentze, W
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2003, 93 (03): : 219 - 223
  • [2] Humalog® Mix25™ improves postprandial glucose response in type 1 and type 2 diabetes
    Yang, H
    Woodworth, JR
    Huang, J
    Campaigne, BN
    Grossman, L
    Malone, JK
    DIABETES, 2000, 49 : A130 - A130
  • [3] Effects of acute physical exercise on blood glucose in patients with type 2 diabetes on treatment with Humalog® Mix25
    Herz, M
    Arora, V
    Profozic, V
    Metelko, Z
    DIABETES, 2000, 49 : A358 - A358
  • [4] The impact of the timing of Humalog® Mix25™ injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes
    Galic, E
    Vrtovec, M
    Bozikov, V
    Schwarzenhofer, M
    Milicevic, Z
    MEDICAL SCIENCE MONITOR, 2005, 11 (12): : PI87 - PI92
  • [5] Humalog® Mix50™ vs. Humalog® Mix25™ before carbohydrate-rich meals in patients with type 2 diabetes
    Roach, P
    Arora, V
    Mattoo, V
    DIABETES, 2000, 49 : A122 - A122
  • [6] Glycemic control with Humalog® Mix25™ in type 2 diabetes inadequately controlled with glyburide
    Roach, P
    Koledova, E
    Metcalfe, S
    Hultman, C
    Milicevic, ZO
    CLINICAL THERAPEUTICS, 2001, 23 (10) : 1732 - 1744
  • [7] Humalog® Mix25™ offers better mealtime glycemic control in patients with type 1 or type 2 diabetes
    Malone, JK
    Yang, H
    Woodworth, JR
    Huang, J
    Campaigne, BN
    Halle, JP
    Yale, JF
    Grossman, LD
    DIABETES & METABOLISM, 2000, 26 (06) : 481 - 487
  • [8] Comparable glycemic control with pre-meal or postmeal infection of Humalog® Mix25™ in elderly patients with type 2 diabetes
    Herz, M
    Sun, B
    Milicevic, Z
    DIABETES, 2001, 50 : A437 - A437
  • [9] Equivalent glycemic control with pre-meal or postmeal Humalog® Mix25™ in elderly patients with type 2 diabetes.
    Herz, M
    Sun, B
    Milicevic, Z
    DIABETOLOGIA, 2001, 44 : A210 - A210
  • [10] Exenatide significantly improved 24-hour average glucose compared to sitagliptin in patients with type 2 diabetes
    Shenouda, S. K.
    Holcombe, J. H.
    Heilmann, C. R.
    DIABETOLOGIA, 2010, 53
12345